Value of Serum Human Epidermal Growth Factor Receptor 2 (HER2)/neu Testing for Early Prediction of Response to HER2/neu-Directed Therapies Is Still an Open One and Deserves Further Study in Large Prospective Trials-Reference-Cited by-同舟云学术

Value of Serum Human Epidermal Growth Factor Receptor 2 (HER2)/neu Testing for Early Prediction of Response to HER2/neu-Directed Therapies Is Still an Open One and Deserves Further Study in Large Prospective Trials

Published:2009-12-20 Issue:36 Volume:27 Page:e273-e273
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Ali Suhail M.¹,Leitzel Kim¹,Lipton Allan¹,Carney Walter P.²,Köstler Wolfgang J.³

Affiliation:

1. Penn State University/Hershey Medical Center, Hershey; Lebanon VAMC, Lebanon, PA

2. Oncogene Science/Siemens HealthCare Diagnostics, Cambridge, MA

3. Medical University of Vienna, Vienna, Austria

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2009.23.4674

Reference2 articles.

1. Utility of Serum HER2 Extracellular Domain Assessment in Clinical Decision Making: Pooled Analysis of Four Trials of Trastuzumab in Metastatic Breast Cancer

2. Serum HER-2/neuand relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: results of a randomized study - SAKK 22/99;BMC Cancer;2020-02-11

2. An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies;PLOS ONE;2020-01-07

3. Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine;Genomics, Proteomics & Bioinformatics;2017-08

4. Serum Human Epidermal Growth Factor 2 Extracellular Domain as a Predictive Biomarker for Lapatinib Treatment Efficacy in Patients With Advanced Breast Cancer;Journal of Clinical Oncology;2016-03-20

5. Challenges in the clinical utility of the serum test for HER2 ECD;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2012-08